Labeled circular DNA molecules for analysis of DNA topology, and topoisomerases and for drug screening
US-10150987-B2 · Dec 11, 2018 · US
US11732286B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11732286-B2 |
| Application number | US-202217670738-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 14, 2022 |
| Priority date | Oct 16, 2020 |
| Publication date | Aug 22, 2023 |
| Grant date | Aug 22, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides assays and methods for studying DNA topology and topoisomerases. The assays and methods utilize a circular plasmid DNA comprising one or more hairpin structures and the ability of T5 exonuclease (T5E) to digest the circular plasmid DNA in a specific configuration. The assays and methods can be used as a high throughput screening for inhibitors of, for example, DNA gyrases and DNA topoisomerases I for anticancer drug and antibiotics discovery.
Opening claim text (preview).
We claim: 1. A method for identifying a DNA intercalator in a sample, comprising adding a circular double-stranded plasmid comprising two hairpin structures upon supercoiling, wherein the circular double-stranded plasmid does not comprise a fluorescent dye; adding a T5 exonuclease (T5E); adding a DNA-staining dye; and determining the presence or absence of the DNA intercalator based on fluorescence in the sample. 2. The method of claim 1 , the circular double-stranded plasmid being in a supercoiled configuration. 3. The method of claim 1 , the circular double-stranded plasmid being converted to a relaxed configuration in the presence of the DNA intercalator in the sample. 4. The method of claim 1 , the circular double-stranded plasmid being pAB1. 5. The method of claim 1 , the DNA-staining dye being Hoechest 33258, SYBR gold, ethidium bromide, EthD-1, or SYBR green. 6. The method of claim 1 , the circular double-stranded plasmid comprising about 15 ATs to about 30 ATs. 7. The method of claim 1 , the circular double-stranded plasmid comprising an adenosine-thymidine dinucleotide repeat (AT)n sequence, wherein n=21. 8. The method of claim 1 , wherein a higher fluorescence in the sample than a control is indicative of the presence of the DNA intercalator, wherein the control comprises the circular supercoiled double-stranded plasmid in the absence of the DNA intercalator. 9. The method of claim 1 , the circular double-stranded plasmid comprising at least one DNA endonuclease recognition site. 10. The method of claim 1 , which comprises incubating T5E in the sample for at least 1 hour prior to adding the DNA-staining dye. 11. The method of claim 1 , which further comprises adding ATP in the sample. 12. The method of claim 1 , the sample being a sample in a high throughput screening (HTS) sample carrier.
involving isomerase · CPC title
involving esterase · CPC title
Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53) · CPC title
with indicators, stains, dyes, tags, labels, marks · CPC title
Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.